Aetna Standardizes 88% of Prior Authorization Volume, Exceeds Industry Commitments for Healthcare Access

Key Takeaways

• Aetna has standardized 88% of its prior authorization volume, exceeding industry-wide commitments for healthcare reform
• The CVS Health subsidiary maintains the fewest medical services requiring prior authorization among national health plans
• These reforms aim to simplify healthcare access for both patients and healthcare providers across Aetna’s network

---

HARTFORD, Conn. - Aetna, a CVS Health company (NYSE: CVS), announced significant progress in prior authorization reform on April 24, 2026, revealing that the health insurer has standardized 88% of its prior authorization volume while maintaining the lowest number of medical services requiring prior authorization among national health plans.

Leading Industry Reform Efforts

The announcement positions Aetna at the forefront of healthcare administration reform, addressing long-standing concerns about prior authorization processes that have historically created barriers between patients and necessary medical care. Prior authorization requirements have been a persistent challenge in healthcare delivery, often delaying treatment while providers navigate approval processes.

IntelligenceRegulatory Impact▾

EMA and MHRA are the agencies to watch. Regulatory relevance reads medium for pharmaceutical intelligence. Teams should track submission types, designations, and guidance shifts that could move approval timelines.

Impact on Healthcare Delivery

Aetna’s standardization efforts represent a substantial improvement in healthcare accessibility. By reducing administrative complexity, the company aims to streamline the approval process for medical treatments and procedures, potentially reducing wait times for patients seeking care.

The 88% standardization rate exceeds broader industry commitments, suggesting Aetna is moving more aggressively than competitors to address prior authorization challenges. This initiative aligns with growing regulatory pressure and industry calls for reform in healthcare administration processes.

IntelligenceCompetitive Intelligence▾

Competitive pressure is low. Watch which sponsors move first. Benchmark pipeline positioning, differentiation, and partnership scouting against the signals in this story.

Market Implications

As part of CVS Health’s broader healthcare ecosystem, these changes could influence how other major health insurers approach prior authorization reform. The company’s position as having the “fewest medical services requiring prior authorization” may provide a competitive advantage in attracting both healthcare providers and patients seeking streamlined access to care.

The reform efforts come amid increasing scrutiny of prior authorization practices from healthcare providers, patient advocacy groups, and regulatory bodies who argue that excessive requirements can delay necessary medical interventions.

---

Frequently Asked Questions

What does prior authorization standardization mean for patients?

Standardization means more consistent, predictable approval processes across different medical services, potentially reducing delays in accessing prescribed treatments and procedures.

How does Aetna’s 88% standardization compare to industry standards?

Aetna’s 88% standardization rate exceeds industry-wide commitments, positioning the company ahead of typical industry benchmarks for prior authorization reform.

Will this reduce the number of services requiring prior authorization?

While Aetna already maintains the fewest prior authorization requirements among national health plans, the standardization focuses on streamlining existing processes rather than necessarily eliminating requirements.

Related coverage

• From Approval to Access: Europe’s Next Health Imperative for Pharma
• BBIA Joins EuropaBio: Strengthening the Bio-Based Economy for Pharma and Industry
• WHO/Europe Initiative on Access to Novel Medicines: Market Implications for Pharma